# N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome

> **NCT03346681** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Prisma Health-Midlands**

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** N-acetyl cysteine

## Key facts

- **NCT ID:** NCT03346681
- **Lead sponsor:** Prisma Health-Midlands
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-02-01
- **Primary completion:** 2021-01-30
- **Final completion:** 2021-01-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no patients enrolled
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346681, "N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03346681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*